BREAST CANCER ANALYSIS OF FORECASTING PARAMETERS TYPICAL FOR CLINICAL PICTURE OF THE DISEASE
https://doi.org/10.51523/2708-6011.2009-6-2-3
Abstract
We study the relationship between major clinical-diagnostic indicators with breast cancer. We show the progression of the disease is characterized by a significant decrease in the number of correlations between the clinical diagnostic and immunogistochemical characteristics of tumor tissue.
About the Author
E. A. Nadyrov
Republican Research Centre of Radiation Medicine and Human Ecology
Belarus
Belarus
References
1. Семиглазов, В. Ф. Значение прогностических и предстказывающих факторов при выборе леяения у больных метастатическим раком молочной железы / В. Ф. Семиглазов // Практическая онкология. - 2000. - № 2. - С. 26-30.
2. Steroid hormone receptors as prognostic ondicators in primary breast cancer / S. M. Thorpe [et al.] // Breast Cancer Res Treat. - 1986. - № 7. - Р. 91-98.
3. Comparative value of tumor grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy / T. Petit [et al.] // Eur J Cancer. - 2004. - № 40 (2). - Р. 205-211.
4. Летягин, В. П. Органосохраняющие операции в комплексном лечении больных раком молочной железы / В. П. Летягин, Н. Н. Волченко // Рос. онкол. журн. - 2001. - № 4. - С. 4-6.
5. Comparative value of tumor grade, hormonal receptors, Ki-67, Her-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy / T. Petit [et al.] // Eur. J. Cancer. - 2004. - Vol. 40 (2). - P. 205-211.
6. Dinshaw, K. A. Profile of prognostic factors in 1022 Indian women with early-stage breast cancer treated with breast-conserving therapy / K. A. Dinshaw, A. N. Budrukkar, R. F. Chinoy // Int. J. Radiat. Oncol. Biol. Phys. - 2005. - Vol. 63, № 4. - P. 1132-1141.
7. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy / P. T. Truong [et al.] // J. Am. Coll. Surg. - 2005. - Vol. 200, № 6. - P. 912-921.
8. Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases / V-J. Bardou [et al.] // J. Clin. Oncol. - 2003. - Vol. 21. - P. 1973-1979.
9. Estrogen receptor positive (ER+), progesterone receptor negative (PgR-) breast cancer: new insights into molecular mechanisms and clinical implications / G. Arpino [et al.] // Breast cancer research and treatment. 27Ih Annual San Antonio Breast Cancer Symposium. - 2004. - Vol. 88. - Р. 105.
10. Hamilton, A. The contribution of molecular markers to the prediction of response in the treatment of breast cancer: a review of the literature on HER-2, p53 and BCL-2 / A. Hamilton, M. Piccart // Ann. Oncol. - 2000. - Vol. 11 (6). - P. 647-663.
11. TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer / A. A. Langerod [et al.] // Breast Cancer Res. - 2007. - № 9 (3). - Р. 30.
12. Evaluation of ER and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancer / J. Lee [et al.] // Cancer Chemother. Pharmacol. - 2008. - № 61 (4). - Р. 569-577.
13. Рroliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapy / A. Vincent-Salomon [et al.] // Eur. J. Cancer. - 2004. - № 40 (10). - Р. 1502-1508.
14. Боровиков, В. STATISTICA. Искусство анализа данных на компьютере: для профессионалов / В. Боровиков. - 2-е изд. (+ CD). - СПб.: Питер, 2003. - 688 с.
15. Gaffney, D. K. Diminished Survival in Patients With Inner Versus Outer Quadrant Breast Cancers / D. K. Gaffney, A. Tsodikov, C. L.Wiggins // J. Clin. Oncol. 2003. - № 21. - Р. 467-472.
16. The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: How young is «young»? / J. L. Oh. [et al.] // Int. J. Radiat. Oncol. Biol. Phys. - 2006. - Vol. 65, № 5. - P. 1345-1352.
Review
For citations:
Nadyrov E.A. BREAST CANCER ANALYSIS OF FORECASTING PARAMETERS TYPICAL FOR CLINICAL PICTURE OF THE DISEASE. Health and Ecology Issues. 2009;(2):17-20. (In Russ.) https://doi.org/10.51523/2708-6011.2009-6-2-3
Views: 273
Email this article 